ArticleLangenbeck's archives of surgery2024

The short-term efficacy and safety of neoadjuvant Sintilimab combined with chemotherapy for resectable gastroesophageal junction adenocarcinoma.

Liji Chen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.